Statement of Organization, Functions, and Delegations of Authority, 71803-71804 [2015-29276]
Download as PDF
<![CDATA[
71803
Federal Register / Vol. 80, No. 221 / Tuesday, November 17, 2015 / Notices
M. tuberculosis susceptibility testing.
Participation in this program is one way
laboratories can ensure high-quality
laboratory testing, resulting in accurate
and reliable testing results.
By providing an evaluation program
to assess the ability of the laboratories
to test for drug resistant M. tuberculosis
strains, laboratories also have a selfassessment tool to aid in optimizing
their skills in susceptibility testing. The
information obtained from the
laboratories on susceptibility practices
and procedures is used to establish
variables related to good performance,
assessing training needs, and aid with
the development of practice standards.
The data collected over the previous
three-year period enabled CDC to
correlate testing practices with
performance and to use this information
to design training modules targeted to
participants encouraging the adaptation
of advanced testing methods. Extension
of data collection will allow CDC to
evaluate the effectiveness of these
training modules by continually
monitoring laboratory performance.
Participants in this program include
domestic clinical and public health
laboratories. Data collection from
laboratory participants occurs twice per
year. The data collected in this program
will include the susceptibility test
results of primary and secondary drugs,
drug concentrations, and test methods
performed by laboratories on a set of
performance evaluation (PE) samples.
The PE samples are sent to participants
twice a year. Participants also report
demographic data such as laboratory
type and the number of tests performed
annually.
There is no cost to respondents to
participate other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Participant Biosafety Compliance Letter of Agreement ...
MPEP Mycobacterium tuberculosis Results Worksheet ..
Online Survey Instrument ................................................
93
93
93
2
2
2
5/60
30/60
15/60
16
93
47
...........................................................................................
93
6
........................
156
Form name
Domestic Laboratory
Total .................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–29272 Filed 11–16–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis Meeting (ACET)
mstockstill on DSK4VPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates:
8:30 a.m.–5:00 p.m., EST, December 15, 2015
8:30 a.m.–12:00 p.m., EST, December 16,
2015
Place: Corporate Square, Corporate
Boulevard, Building 8, 1st Floor Conference
Room, Atlanta, Georgia 30329, telephone
(404) 639–8317.
This meeting is also accessible by Webinar:
December 15, 2015
For Participants:
URL: https://www.mymeetings.com/nc/join/
Conference number: PW1126536
Audience passcode: 6816256
Participants can join the event directly at:
VerDate Sep<11>2014
Average
burden per
response
(in hours)
Number of
respondents
Type of respondent
18:14 Nov 16, 2015
Jkt 238001
https://www.mymeetings.com/nc/join.php?i=
PW1126536&p=6816256&t=c
USA Toll-free +1 (888) 947–9021, Participant
code: 6816256
December 16, 2015
For Participants:
URL: https://www.mymeetings.com/nc/join/
Conference number: PW5803596
Audience passcode: 6816256
Participants can join the event directly at:
https://www.mymeetings.com/nc/join.php?i=
PW5803596&p=6816256&t=c
USA Toll-free +1 (888) 947–9021, Participant
code: 6816256
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 100 people.
Purpose: This Council advises and makes
recommendations to the Secretary of Health
and Human Services, the Assistant Secretary
for Health, and the Director, CDC, regarding
the elimination of tuberculosis. Specifically,
the Council makes recommendations
regarding policies, strategies, objectives, and
priorities; addresses the development and
application of new technologies; and reviews
the extent to which progress has been made
toward eliminating tuberculosis.
Matters for Discussion: Agenda items
include the following topics: (1) Overview of
Biomedical Advanced Research and
Development Authority (BARDA); (2)
Tuberculosis in Congregate Settings; (3)
Updates from Workgroups; and (4) other
tuberculosis-related issues.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Margie Scott-Cseh, Centers for Disease
Control and Prevention, 1600 Clifton Road
NE., M/S E–07, Atlanta, Georgia 30333,
telephone (404) 639–8317 Email: zkr7@
cdc.gov.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Total burden hours
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–29260 Filed 11–16–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 80 FR 58479–58485,
dated September 29, 2015) is amended
to reflect the reorganization of the
National Center for Immunization and
Respiratory Diseases, and the Office of
Infectious Diseases, Centers for Disease
Control and Prevention.
E:\FR\FM\17NON1.SGM
17NON1
mstockstill on DSK4VPTVN1PROD with NOTICES
71804
Federal Register / Vol. 80, No. 221 / Tuesday, November 17, 2015 / Notices
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the title and
function statements for the Influenza
Coordination Unit (CVA4).
Delete in its entirety the title and
function statements for the National
Center for Immunization and
Respiratory Diseases (CVG) and insert
the following:
National Center for Immunization
and Respiratory Diseases (CVG). The
National Center for Immunization and
Respiratory Diseases (NCIRD) prevents
disease, disability, and death through
immunization and by control of
respiratory and related diseases. In
carrying out its mission, NCIRD: (1)
Provides leadership, expertise, and
service in laboratory and
epidemiological sciences, and in
immunization program delivery; (2)
conducts applied research on disease
prevention and control; (3) translates
research findings into public health
policies and practices; (4) provides
diagnostic and reference laboratory
services to relevant partners; (5)
conducts surveillance and research to
determine disease distribution,
determinants, and burden nationally
and internationally; (6) responds to
disease outbreaks domestically and
abroad; (7) ensures that public health
decisions are made objectively and
based upon the highest quality of
scientific data; (8) provides technical
expertise, education, and training to
domestic and international partners; (9)
provides leadership to internal and
external partners for establishing and
maintaining immunization, and other
prevention and control programs; (10)
develops, implements, and evaluates
domestic and international public
health policies; (11) communicates
information to increase awareness,
knowledge, and understanding of public
health issues domestically and
internationally, and to promote effective
immunization programs; (12) aligns the
national center focus with the overall
strategic goals of CDC; (13) synchronizes
all aspects of CDC’s pandemic influenza
preparedness and response from
strategy through implementation and
evaluation; and (14) implements,
coordinates, and evaluates programs
across NCIRD, Office of Infectious
Diseases (OID), and CDC to optimize
public health impact.
After the Office of Science and
Integrated Programs (CVG17) insert the
following:
Influenza Coordination Unit (CVG18).
The mission of the Influenza
Coordination Unit (ICU) is to
synchronize all aspects of CDC’s
VerDate Sep<11>2014
18:14 Nov 16, 2015
Jkt 238001
pandemic influenza preparedness and
response from strategy through
implementation and evaluation. In
carrying out its mission, the ICU: (1)
Serves as the principal advisor to the
CDC Director on pandemic influenza
preparedness and response activities,
assisting the Director in formulating and
communicating strategic pandemic
initiatives and policies; (2) provides
strategic leadership for CDC in the areas
of pandemic preparedness and
response, including setting priorities
and promoting science, policies, and
programs related to pandemic influenza;
(3) strategically manages a budget and
allocates funds across the agency to
ensure appropriate resources for high
priority areas; and (4) conducts ongoing
evaluation and adjustment of pandemic
preparedness and response activities, in
coordination with the National
Response Framework and other
emergency preparedness guidance, to
ensure optimal public health
effectiveness and efficient use of human
and fiscal resources by developing and
leading an exercise program for the
Agency, in collaboration with HHS and
other partners.
James Seligman,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2015–29276 Filed 11–16–15; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Infectious Diseases: Notice of
Charter Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the Board
of Scientific Counselors, Office of
Infectious Diseases, Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS), has been renewed for a
2-year period through October 31, 2017.
For information, contact Robin
Moseley, M.A.T., Designated Federal
Officer, Board of Scientific Counselors,
Office of Infectious Diseases, CDC, HHS,
1600 Clifton Road NE., Mailstop D10,
Atlanta, Georgia 30329–4027, telephone
404/639–4461 or fax 404/235–3562.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–29258 Filed 11–16–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–16–0964]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
E:\FR\FM\17NON1.SGM
17NON1
]]>Agencies
[Federal Register Volume 80, Number 221 (Tuesday, November 17, 2015)]
[Notices]
[Pages 71803-71804]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-29276]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 80 FR 58479-58485, dated September 29, 2015)
is amended to reflect the reorganization of the National Center for
Immunization and Respiratory Diseases, and the Office of Infectious
Diseases, Centers for Disease Control and Prevention.
[[Page 71804]]
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete in its entirety the title and function statements for the
Influenza Coordination Unit (CVA4).
Delete in its entirety the title and function statements for the
National Center for Immunization and Respiratory Diseases (CVG) and
insert the following:
National Center for Immunization and Respiratory Diseases (CVG).
The National Center for Immunization and Respiratory Diseases (NCIRD)
prevents disease, disability, and death through immunization and by
control of respiratory and related diseases. In carrying out its
mission, NCIRD: (1) Provides leadership, expertise, and service in
laboratory and epidemiological sciences, and in immunization program
delivery; (2) conducts applied research on disease prevention and
control; (3) translates research findings into public health policies
and practices; (4) provides diagnostic and reference laboratory
services to relevant partners; (5) conducts surveillance and research
to determine disease distribution, determinants, and burden nationally
and internationally; (6) responds to disease outbreaks domestically and
abroad; (7) ensures that public health decisions are made objectively
and based upon the highest quality of scientific data; (8) provides
technical expertise, education, and training to domestic and
international partners; (9) provides leadership to internal and
external partners for establishing and maintaining immunization, and
other prevention and control programs; (10) develops, implements, and
evaluates domestic and international public health policies; (11)
communicates information to increase awareness, knowledge, and
understanding of public health issues domestically and internationally,
and to promote effective immunization programs; (12) aligns the
national center focus with the overall strategic goals of CDC; (13)
synchronizes all aspects of CDC's pandemic influenza preparedness and
response from strategy through implementation and evaluation; and (14)
implements, coordinates, and evaluates programs across NCIRD, Office of
Infectious Diseases (OID), and CDC to optimize public health impact.
After the Office of Science and Integrated Programs (CVG17) insert
the following:
Influenza Coordination Unit (CVG18). The mission of the Influenza
Coordination Unit (ICU) is to synchronize all aspects of CDC's pandemic
influenza preparedness and response from strategy through
implementation and evaluation. In carrying out its mission, the ICU:
(1) Serves as the principal advisor to the CDC Director on pandemic
influenza preparedness and response activities, assisting the Director
in formulating and communicating strategic pandemic initiatives and
policies; (2) provides strategic leadership for CDC in the areas of
pandemic preparedness and response, including setting priorities and
promoting science, policies, and programs related to pandemic
influenza; (3) strategically manages a budget and allocates funds
across the agency to ensure appropriate resources for high priority
areas; and (4) conducts ongoing evaluation and adjustment of pandemic
preparedness and response activities, in coordination with the National
Response Framework and other emergency preparedness guidance, to ensure
optimal public health effectiveness and efficient use of human and
fiscal resources by developing and leading an exercise program for the
Agency, in collaboration with HHS and other partners.
James Seligman,
Acting Chief Operating Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2015-29276 Filed 11-16-15; 8:45 am]
BILLING CODE 4160-18-P
